Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages...
Pre-market hot trades in US stocks: Planet Green fell 3.89% in pre-market; IREN rose 3.82% in pre-market
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
Caitong Securities: The demand for phosphonamide monomers will flourish, and multinational pharmaceutical companies' supply chain enterprises are expected to benefit
Furui Co., Ltd: Net profit in the third quarter was 59.9522 million yuan, a year-on-year increase of 125.06%
Furui Co., Ltd. released its performance for the first half of the year, with a net profit attributable to the parent company of 51.934 million yuan, a decrease of 31.09%